Nevertheless, evidence has accumulated indicating that high preoperative HE4 levels are significantly associated with an unfavorable prognosis in ovarian cancer patients and significantly associated with risk of an incomplete tumor resection [87,88]. The gene discussed is WFDC2; the disease is neoplasm.